Last week, the Centers for Disease Control and Prevention issued a warning against holiday travel. The day after 1 million Americans got on a plane, it’s the highest volume of travelers airports have seen since the pandemic.
Guests: Axios’ Joann Muller, and Russell Contreras and State University of New York Chancellor Jim Malatras.
Radio News 24/7 reports: PFIZER AND BIONTECH apply for emergency Covid-19 vaccine authorization, G-20 meeting in Saudi Arabia, and other top world news.
CDC urges Americans not to travel for Thanksgiving, sitting President claims broad conspiracy to manipulate election, and FedEx driver gives new basketball hoop to Indiana boy in act of kindness.
The COVID-19 mortality rate is falling around the world. We discuss the reasons behind this – the role of new drugs, the treatment strategies the have been learned, or re-learned, and the ever-present worry that these hard won victories could be undone by rising infection rates.
In this episode:
00:44 An increase in survival rates
The COVID-19 mortality rate is falling around the world. We discuss the reasons behind this – the role of new drugs, the treatment strategies the have been learned, or re-learned, and the ever-present worry that these hard won victories could be undone by rising infection rates.
News Feature: Why do COVID death rates seem to be falling?
10:53 More vaccine good news
This week, Moderna released preliminary results for its COVID-19 vaccine candidate, the third positive indication from a string of vaccine announcements. Although the full data are yet to be published, do these results give us more reasons to feel hopeful?
News: COVID vaccine excitement builds as Moderna reports third positive result
NPR News Now reports; 250,000 deaths from Covid-19 surpassed, NYC schools shift to online instruction, Georgia recount to conclude today.
A vaccine for covid-19 could be rolled out before the end of the year. But a worrying rise in mistrust of vaccines threatens its effectiveness. Now & Next is a series from The Economist Films: https://films.economist.com/nowandnext/
The President fires top cybersecurity official who defended integrity of election, new coronavirus restrictions in place as record 73,000 hospitalized, and runaway dog from Canada crosses border into United States.
Early data from US biotech Moderna has revealed that its Covid-19 vaccine candidate is 94.5 per cent effective, raising hopes that a range of immunisations will be available to help end the pandemic. The interim analysis of the vaccine, currently known as mRNA-1273, comes after 95 trial participants contracted Covid-19, including just five who were given the coronavirus jab. While the data was published via a press release, it includes significant details that remain unclear around the Pfizer-BioNTech vaccine – which uses the same mRNA technology to target the coronavirus spike protein and an immune response.
Boomers Daily 